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Background: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic destructive
inflammation in synovial joints. It is well known that genetic and environmental risk factors and their interaction
contribute to RA pathogenesis. This study aimed to investigate the association between the critical polymorphisms
in the tumor necrosis factor α (TNFα)-induced protein 3(TNFAIP3) gene and the risk of RA in a large northern Chinese
Han population.
Methods: A case–control study of 1280 RA patients and 1280 matched healthy controls was conducted.
Results: This study showed that carriers of the rs2230926 TG genotype or rs10499194 CT genotype had an increased
risk for RA compared with those carrying the wild genotype (rs2230926: OR = 1.48, 95% CI = 1.17-1.86, p = 0.001;
rs10499194: OR = 2.00, 95% CI = 1.46-2.74, p < 0.001). The combined rs2230926TG/GG or rs10499194 CT/TT were
associated with an increased risk of RA (ORs were 1.50 and 2.01, 95% CIs were 1.19-1.88 and 1.47-2.74, respectively,
both p < 0.001). There was not significant association between rs13207033 polymorphism and RA risk. Subset
analysis stratified to gender showed that the increased risks were significant among the genotypes TG, TG/GG of
rs2230926 and CT, CT/TT of rs10499194 and the corresponding ORs were 1.42 (95% CI = 1.10-1.83, p = 0.006), 1.44
(95% CI = 1.12-1.85, p = 0.004), 1.52(95% CI = 1.05-2.20, p = 0.026) and 1.52(95% CI = 1.06-2.19, p = 0.023) in the female
population. Stratified analyses by age found that rs2230926(TG, TG/GG) and rs10499194(CT, CT/TT) polymorphisms
were associated with RA risks in population ≤53 years old and among >53 years old only rs10499194(CT, TT, CT/TT)
polymorphism had significant results. The interaction analysis suggested that individuals with both risk genotypes of
the two SNPs have a higher elevated risk of RA than those with only one of them (ORs were 3.44 compared to 1.74
and 1.35). The haplotype results showed that individuals with the rs2230926G-rs13207033G-rs10499194C haplotype
were associated with increased risks of RA (OR = 1.37, 95% CI = 1.08-1.74, p = 0.010).
Conclusions: Rs10499194 and rs2230926 polymorphisms in the TNFAIP3 gene region may be susceptibility factors for
rheumatoid arthritis in the northern Chinese Han population.
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Rheumatoid arthritis (RA) is a systemic autoimmune
disease. It is characterized by chronic destructive inflam-
mation in synovial joints. It is well known that genetic
and environmental risk factors and their interaction con-
tribute to RA pathogenesis [1]. So far the etiology is still
not understood, but the genetic factors significantly con-
tribute to RA with heritability estimated more than half
(53-60%) [2]. The key role of nuclear factor-κB (NF-κB)-
dependent gene expression in the development of auto-
immune diseases including RA is generally accepted.
TNFAIP3(A20), as a deubiquitinating protein, can de-
regulate NF-κB-dependent gene expression and inhibit
NF-κB function by deubiquitinating specific NF-κB sig-
naling molecules [3,4]. Defects in A20 expression are as-
sociated with development of many human autoimmune
diseases [5]. The development of severe inflammation of
the joints are found in A20-deficient mice [6]. A20 defi-
ciency in myeloid cells spontaneously develops a severe
destructive polyarthritis with many features of RA in
mice [7]. Loss of A20 in B cells causes inflammation and
leads to autoimmune pathology in old mice [8]. In
addition, Kool et al. found that A20-mediated control of
dendritic cells (DC) activation as a crucial checkpoint in
the development of systemic autoimmunity [9]. DCs need
A20 to preserve immune quiescence and prevents colitis
and spondyloarthritis in mice [10].
More recently, studies shown that several single nu-
cleotide polymorphisms (SNPs) in human TNFAIP3 loci
involve in increased susceptibility to RA [5]. The as-
sociated SNPs (rs6920220 and rs10499194) are located
near oligodendrocyte transcription factor 3(OLIG3)
and TNFAIP3 genes [6]. Studies in Caucasian popula-
tions identified that SNPs in the candidate loci, such as
rs6920220, rs13207033, rs582757 and et al., are associated
with RA [4,11-13]. Rs10499194 was initially identified in
North American ACPA + patients [12]. An association
between F127C and A125V human polymorphism in
TNFAIP3 and autoimmunity in African Americans was
reported by Lodolce JP. et al. [14]. The majority of RA risk
alleles previously validated for RA patients of European
ancestry showed similar ORs in the population of African
Americans with RA [15]. Studies which tested the 6q23
region in Tunisian population revealed a trend of an asso-
ciation of rs6920220-A allele with RA and genotypes
containing this allele were in a higher proportion in RA pa-
tients than in matched controls [16]. Lately the association
of TNFAIP3 SNPs with RA was replicated in Japanese and
Korean populations [17,18].
To identify the role of the polymorphisms in the
TNFAIP3 gene on the risk of RA in Asian population, in
the present study, we describe a case–control study of
1280 RA cases and 1280 controls from northern Chinese
han population; stratified analyses were carried on bygender and age; we also explored the interaction between
genetic polymorphisms in the development of RA.
Methods
Study subjects and data collection
The present case–control study, conducted between July
2010 and December 2013, included 1280 diagnosed RA
patients and 1280 healthy controls. All RA cases were
selected following the diagnostic features of RA estab-
lished by the American College of Rheumatology criteria
[19]. At the same time, unrelated healthy control subjects
without any indication of RA were selected. Controls
were all frequency matched to cases on age (±3 years)
and gender. The human investigations were approved by
the Ethics Committee of Shengjing Hospital of China
Medical University, and informed consents were obtained
from each participant. All patients were unrelated ethnic
Han Chinese. Each participant donated 2 ml venous blood
and was interviewed to collect the demographic data.
Three SNPs of the TNFAIP3 gene were analyzed in the
present study: rs10499194, rs2230926 and rs13207033.
DNA isolation and genotyping
Genomic DNA samples were isolated using the phenol–
chloroform method. SNPs were analyzed by TaqMan
assays. For the selected SNPs, designed TaqMan SNP
genotyping assays were used. Primers and probes were
synthesized by Shanghai Generay Biotechnology Co, Ltd.
(P.R. China). The sequences of probes and primers are
listed as follows: rs2230926, forward primer: GAT TTG
AGA GAC TCC AGT TGC CA, reverse primer: GCG
TTC AGG ACA CAG ACT TGG, probe 1: FAM-AGC
GTG CTG AAC AGC GCC TTC-TAMRA, probe 2:
HEX-AGC GTG CTG CAC AGC GCC T-TAMRA;
rs13207033, forward primer: GCA CAA TGA AAG
AGA GAG AAG TAG AAT AAT, reverse primer: ATC
AAC ATT TGT CTA TTT TAT GCT CCA, probe 1:
FAM-TAC AGA TTT CAC TTT CCC T-MGB, probe 2:
HEX-CTA CAG ATT TTA CTT TCC-MGB; rs10499194,
forward primer: GCT ATC AGT TTC ATT ACC TAA
GAA ATA GAG AC, reverse primer: CAA CGG ATA
AGC AAT CAG ACC A, probe 1: FAM-AAT GTG TTC
AAC CCT TT-MGB, probe 2: HEX-CAA ATG TGT TTA
ACC CTT T-MGB. Fluorescence was detected using
an ABI Prism 7500 Sequence Detection System (Applied
Biosystems). A 10% masked random sample of subjects
was tested twice by different persons for quality control,
and the results were found to be in agreement for all of the
duplicate sets.
Statistical analysis
Pearson’s chi-square test was used to compare the distri-
bution of the demographic variables and SNP genotypes
between cases and controls. Hardy-Weinberg equilibrium
Table 1 Association between polymorphisms in TNFAIP3
gene and rheumatoid arthritis in northern Chinese han
subjects
Genotype Cases (%) Controls (%) OR (95% CI) p value
rs2230926
TT 1072(83.8) 1133(88.5) 1.00 —
TG 200(15.6) 143(11.2) 1.48(1.17-1.86) 0.001
GG 8(0.6) 4(0.3) 2.11(0.64-7.04) 0.223
TG/GG 208(16.2) 147(11.5) 1.50(1.19-1.88) <0.001
rs13207033
GG 1040(81.3) 1048(81.9) 1.00 —
GA 232(18.1) 216(16.9) 1.08(0.88-1.33) 0.448
AA 8(0.6) 16(1.2) 0.50(0.22-1.18) 0.115
GA/AA 240(18.7) 232(18.1) 1.04(0.85-1.27) 0.683
rs10499194
CC 1156(90.3) 1215(94.9) 1.00 —
CT 120(9.4) 63(4.9) 2.00(1.46-2.74) <0.001
TT 4(0.3) 2(0.2) 2.10(0.38-11.50) 0.392
CT/TT 124(9.7) 65(5.1) 2.01(1.47-2.74) <0.001
Data were calculated by unconditional logistic regression.
Table 2 Polymorphisms in TNFAIP3 gene and risks of
rheumatoid arthritis in females
Genotype Cases (%) Controls (%) OR [95% CI] p value
rs2230926
TT 912(83.8) 918(88.2) 1.00
TG 168(15.5) 119(11.4) 1.42[1.10-1.83] 0.006
GG 8(0.7) 4(0.4) 2.01[0.60-6.71] 0.255
TG/GG 176(16.2) 123(11.8) 1.44[1.12-1.85] 0.004
rs13207033
GG 904(83.1) 872(83.8) 1.00
GA 176(16.2) 159(15.2) 1.07[0.85-1.35] 0.583
AA 8(0.7) 10(1.0) 0.77[0.30-1.96] 0.587
GA/AA 184(16.9) 169(16.2) 1.05[0.84-1.32] 0.674
rs10499194
CC 1009(92.7) 990(94.2) 1.00
CT 76(7.0) 49(4.6) 1.52[1.05-2.20] 0.026
TT 3(0.3) 2(0.2) 1.47[0.25-8.83] 0.672
CT/TT 79(7.3) 51(4.8) 1.52[1.06-2.19] 0.023
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goodness-of-fit χ2 test. Unconditional logistic regression
analysis was performed to calculate the odds ratios (OR)
with 95% confidence intervals (CI) for estimating the asso-
ciation between certain genotypes and RA. The interac-
tions were evaluated by cross-over analysis and logistic
regression models. All statistical analyses were performed
with SPSS (v16.0), if not otherwise specified. All of the tests
were two-sided, and statistical significance was defined as
p < 0.05. On the basis of the observed frequencies of the
three SNPs, we used the SHEsis analysis platform to calcu-
late linkage disequilibrium indices (D’ and r2) and infer
haplotype frequencies [20,21].
Results
In total, 1280 RA patients and 1280 healthy controls
were included in the present study. There were 1088 fe-
males and 192 males in the case group, and 1051 females
and 229 males in the control group. The mean ages of the
cases and controls (mean ± S.D.) were almost identical
(53.99 ± 13.61 and 53.52 ± 8.63 years, respectively). The
distributions of gender or age between the case and control
groups were identical.
The frequencies of the rs2230926 G allele, rs13207033
A allele and rs10499194 T allele were 0.059, 0.097, 0.030,
respectively, in the controls and 0.084, 0.097, 0.053, re-
spectively, in the cases. All allele distributions were con-
sistent with HWE (p values were 0.819, 0.203, 0.218 in
controls and 0.687, 0.200, 0.638 in cases for the SNPs,
respectively).
Table 1 present the distribution of genotypes for poly-
morphisms in the TNFAIP3 gene in cases and controls.
Among these SNPs, rs2230926 and rs10499194 were as-
sociated with the risks of RA, however the rs13207033
polymorphism was not associated with RA risk in this
study. The heterozygous carriers of the rs2230926 TG
genotype had a 1.48-fold risk of RA compared with
the homozygous wild genotype TT (95% CI = 1.17-1.86,
p = 0.001). Individuals carrying the rs10499194 CT het-
erozygous genotype had a 2.00-fold increased risk of
RA compared with the homozygous wild genotype CC
(95% CI = 1.46-2.74, p < 0.001). Analyses combining the
heterozygous variant genotype with the homozygous
variant genotype showed that the combined rs2230926
TG/GG and rs10499194 CT/TT were associated with in-
creased risks of RA (ORs were 1.50 and 2.01, 95%CIs were
1.19-1.88 and 1.47-2.74, respectively, both p < 0.001). The
overall ORs with its 95%CIs didn’t show statistically asso-
ciation between rs13207033 polymorphism and RA risk
(GA vs. GG: OR = 1.08, 95%CI = 0.88-1.33, p = 0.448; AA
vs. GG: OR = 0.50, 95%CI = 0.22-1.18, p = 0.115; GA + AA
vs. GG: OR = 1.04, 95%CI = 0.85–1.27, p = 0.683).
Considering that RA occurred more often in fe-
males, we conducted a subset analysis in Chinese femalepopulation (Table 2). The results showed that the in-
creased risks were significant among the rs2230926 variant
genotypes (TG) and rs10499194 variant genotypes (CT)
and the corresponding ORs were 1.42 (95%CI = 1.10-1.83,
p = 0.006) and 1.52 (95%CI = 1.05-2.20, p = 0.026), respect-
ively. The subjects with TG or GG genotype of rs2230926
and CT or TT genotype of rs10499194 were in higher risks
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1.12-1.85 and 1.06-2.19, p = 0.004 and 0.023, respectively).
Significant associations were not seen in the rs13207033
polymorphism (GA vs. GG: OR = 1.07, 95% CI = 0.85-
1.35, p = 0.583; AA vs. GG: OR = 0.77, 95%CI = 0.30-1.96,
p = 0.587; GA +AA vs. GG: OR = 1.05, 95%CI = 0.84–1.32,
p = 0.674).
Furthermore, stratified analyses were adopted by
age and the population was divided into two groups
for ≤53 years old and >53 years old (Table 3). Age 53
was selected because it is the mean age of the present
population and sample size is reasonable in stratified
groups. For rs2230926 polymorphism, the significant re-
sults were found in ≤53 years old group (TG vs. TT:
OR = 1.73, 95%CI = 1.26-2.39; TG +GG vs. TT: OR = 1.80,
95%CI = 1.31-2.47), but not in > 53 years old (TG vs. TT:
OR = 1.30, 95%CI = 0.93-1.80; TG +GG vs. TT: OR = 1.28,
95%CI = 0.92-1.76). In terms of rs10499194 polymorph-
ism, the associations were significant in both ≤53 years
old and >53 years old groups. Individuals carrying the
CT genotype were more likely to develop RA among
people ≤53 years old (OR = 1.89, 95% CI = 1.24-2.90)
and >53 years old(OR = 2.25, 95%CI = 1.39-3.63). Individ-
uals with the TT genotype was more likely to develop RA
among people >53 years old(OR = 2.81, 95%CI = 0.29-
27.07). The significant results were also seen in CT/TT
with ORs 1.88 and 2.27, 95%CIs 1.24-2.86 and 1.42-3.63,
for the subjects ≤53 years old and >53 years old, respect-
ively. For rs13207033 polymorphism, the results in two
stratified groups were all not significant.
Our results revealed a significant association between
the risk of RA and both rs2230926 and rs10499194,Table 3 Polymorphisms in TNFAIP3 gene and risks of rheuma
Genotype ≤53
Cases (%) Controls (%) OR [95%
rs2230926
TT 452(80.7) 564(88.3) 1.00
TG 104(18.6) 75(11.7) 1.73[1.26-2
GG 4(0.7) 0(0.0) —
TG/GG 108(19.3) 75(11.7) 1.80[1.31-2
rs13207033
GG 472(84.3) 528(82.6) 1.00
GA 84(15.0) 107(16.7) 0.88[0.64-1
AA 4(0.7) 4(0.6) 1.12[0.28-4
GA/AA 88(15.7) 111(17.4) 0.89[0.65-1
rs10499194
CC 499(89.1) 600(93.9) 1.00
CT 60(10.7) 38(5.9) 1.89[1.24-2
TT 1(0.2) 1(0.2) 1.20[0.08-19
CT/TT 61(10.9) 39(6.1) 1.88[1.24-2when comparing allele frequency in patients and control
subjects (ORs were 1.47 and 1.96, 95%CIs were 1.19-1.82
and 1.45-2.65, respectively, both p < 0.001) (Table 4).
We evaluated the interaction of rs2230926 and
rs10499194 on the risk of RA using cross-over ana-
lysis and logistic regression model (Table 5). The results
suggested that individuals with both risk genotypes of the
two SNPs have a higher elevated risk of RA than those
with only one of them (ORs were 3.44 compared to 1.74
and 1.35).
Table 6 showed the haplotype analysis results. The
three SNPs were in linkage disequilibrium in the present
population. Three of eight possible haplotypes had a fre-
quency of >0.03 among both cases and controls and
were included in the haplotype analysis. Three possible
haplotypes represented 94.3% of the chromosomes for
the cases and 96.8% for the controls. According to
our priori hypothesis and the SNP-based analyses, we con-
sidered the individuals with the rs2230926T-rs13207033G-
rs10499194C haplotype to be the reference group for
OR estimations. The G-G-C haplotype was associated
with increased risks of RA (OR = 1.37, 95%CI = 1.08-1.74,
p = 0.010).
Discussion
The 6q23 region has recently been associated with dis-
ease susceptibility in RA. This region contains no known
transcripts. The clearest candidate gene among the flank-
ing of this locus with known function is TNFAIP3 gene.
TNFAIP3 encodes protein A20, a TNFα-induced negative
regulator of NF-κB activity, resulting in increased inflam-
mation. This observation makes TNFAIP3/A20 and thetoid arthritis stratified by age
>53
CI] Cases (%) Controls (%) OR [95% CI]
620(86.1) 569(88.8) 1.00
.39] 96(13.3) 68(10.6) 1.30[0.93-1.80]
4(0.6) 4(0.6) 0.92[0.23-3.69]
.47] 100(13.9) 72(12.2) 1.28[0.92-1.76]
568(78.9) 520(81.1) 1.00
.20] 148(20.6) 109(17.0) 1.24[0.95-1.64]
.50] 4(0.6) 12(1.9) 0.31[0.10-0.95]
.20] 152(21.1) 121(18.9) 1.15[0.88-1.50]
657(91.3) 615(95.9) 1.00
.90] 60(8.3) 25(3.9) 2.25[1.39-3.63]
.27] 3(0.4) 1(0.2) 2.81[0.29-27.07]
.86] 63(8.7) 26(4.1) 2.27[1.42-3.63]
Table 4 Allele frequencies of polymorphisms in TNFAIP3




Allele frequency OR (95% CI) p value
Cases Controls
rs2230926, T/G 0.916/0.084 0.941/0.059 1.47(1.19-1.82) <0.001
rs13207033, G/A 0.903/0.097 0.903/0.097 1.00(0.83-1.20) 0.999
rs10499194, C/T 0.947/0.053 0.970/0.030 1.96(1.45-2.65) <0.001
Table 6 Association of haplotypes and risk of rheumatoid
arthritis
Haplotype Cases (%) Controls (%) OR (95% CI) p value
T-G-C 2108(82.3) 2178(85.1) 1.00
T-A-C 142(5.5) 174(6.8) 0.84(0.67-1.06) 0.145
G-G-C 167(6.5) 126(4.9) 1.37(1.08-1.74) 0.010
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flammation also in RA. Therefore, we studied the associ-
ation of SNPs in TNFAIP3 gene and RA risks in a large
northern Chinese han population. Our results suggest that
polymorphisms in the TNFAIP3 gene were associated with
RA susceptibility. Therefore, it seems possible that this re-
gion contains some genetic factors involved in RA.
To date, the majority of GWAS and subsequent meta-
analyses of GWAS data in RA have focused on individ-
uals of European and East Asian ancestry. It has become
clear from these and other large-scale genetic studies of
complex diseases such as RA that genetic risk loci can
differ between these different ethnic groups [22-24]. In
the present study, we sought to test the hypothesis that
RA risk SNPs validated in populations of other country
would also be associated with RA in a large northern
Chinese han population.
The GWAS conducted in the WTCCC study and a
replication study using the WTCCC data demonstrated
associated SNPs for RA at 6q23 [12,25]. Studies in the
Caucasian population have consistently shown that SNPs
at the TNFAIP3 locus might increase the susceptibility
to RA [26,27]. Rs2230926 and rs10499194 polymor-
phisms have been reported to be closely associated with
risk of RA in Japanese subjects [18]. In contrast, Han
et al. have not found the significant association between
rs10499194 polymorphism and the RA risk in Korean
population [17]. Furthermore, it reported no association
between rs10499194 and RA in African-Americans [15].
Our study found the significant association between RA
and the TNFAIP3 gene variants. In the present study,
rs2230926, located in exon 3 of TNFAIP3, was signifi-
cantly associated with a predisposition to RA in northernTable 5 Interaction of rs2230926 and rs10499194 on risk
of rheumatoid arthritis in northern Chinese han subjects
rs2230926 rs10499194 CC CT
Cases/
Controls
OR (95% CI)* Cases/
Controls
OR (95% CI)
TT 989/1080 1.00 83/52 1.74(1.22-2.49)
TG/GG 167/135 1.35(1.06-1.72) 41/13 3.44(1.84-6.47)
*OR and 95% CI were calculated by logistic regression, with the rs2230926
wild genotype (TT) as the reference group.Chinese han subjects. SNP rs2230926 (T/G) is a nonsy-
nonymous variant that results in a phenylalanine-to-
cysteine change at residue 127 of the A20 protein. It is
reported that A20 127Cys protein (encoded by the risk
allele of G) was less effective at inhibiting TNF-induced
NF-κB activity than the Phe127 protein (encoded by the
T allele) [28], which suggests that reduced negative regu-
latory activity of the A20 protein may allow excessive im-
mune activity, leading to enhanced autoreactivity. SNP
rs10499194, one of the landmark polymorphisms identi-
fied in Caucasian patients with RA [12,26], was suggested
to be a susceptibility factor of RA in our population. But
its significant association with RA could not be replicated
in another Caucasian population [29]. Rs10499194 was
also showed to be associated with RA susceptibility in
Japanese population [18]. Because rs10499194 is also
associated with RA susceptibility in our population,
rs10499194 might be a landmark for disease causal variants
in northern Chinese han patients with RA. However, for
another SNP in the 6q23 intergenic region, rs13207033, we
found no association with RA risk. This is in agree-
ment with another study [13]. On the other hand, previ-
ous report supported the significant association of the
rs13207033 SNP with RA [12,25]. The reason for these
different conclusions is not clear now. There are at least
3 explanations for these differences. First, it might be at-
tributable to weak correlations between SNPs and actual
risk of RA. It is known from the International HapMap
Project that the linkage disequilibrium structure between
European and African-American populations may be dif-
ferent for common SNPs in any given locus. Such an ef-
fect may be particularly striking if the causal allele is rare
in the population (e.g., frequency 5%). Second, these dif-
ferences may be explained by genetic heterogeneity; a risk
allele in European patients with RA may have different
effect in Asians. Such population-specific differences may
also reflect gene–gene or gene–environment interactions.
Third, the inconsistency may simply be attributable to
chance. Thus, further analysis in other sample popula-
tions will be required to confirm the association between
SNPs in TNFAIP3 gene and RA risks. The exact effects
and mechanisms of these polymorphisms on RA need
further studies to elucidate.
In summary, our study sheds light on the relationship
between polymorphisms in TNFAIP3 gene and the sus-
ceptibility to RA in northern Chinese han population.
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http://www.biomedcentral.com/1471-2350/15/56Our results show that the SNPs rs2230926 and rs10499194
may be strong causal variant candidates of RA in this
region. While the functional interpretation remains elu-
sive, a search for additional causal variants in TNFAIP3
is required. Moreover, combination of genetic factors
together with environmental exposures should also be
considered.Conclusions
Rs10499194 and rs2230926 polymorphisms in the
TNFAIP3 gene region may be susceptibility factors
for rheumatoid arthritis in the northern Chinese Han
population.
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